It was demonstrated that targeting FABP5 with SBFI-1143 or SBFI-103 leads to substantial remodeling of the transcriptomic PCa landscape by downregulating multiple genes involved in the cell cycle and division and significantly reduces the expression levels of the signature genes involved in the progression towards aggressive PCa. The gene discussed is FABP5; the disease is posterior cortical atrophy.